Insider Transactions in Q4 2020 at Editas Medicine, Inc. (EDIT)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2020
|
Charles Albright EVP/Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-10.39%
|
$630,000
$63.66 P/Share
|
|
Dec 15
2020
|
Charles Albright EVP/Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+22.27%
|
$160,000
$16.51 P/Share
|
|
Dec 09
2020
|
Charles Albright EVP/Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-28.65%
|
$450,000
$45.0 P/Share
|
|
Dec 09
2020
|
Charles Albright EVP/Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+22.27%
|
$160,000
$16.51 P/Share
|
|
Dec 07
2020
|
Charles Albright EVP/Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-44.54%
|
$800,000
$40.02 P/Share
|
|
Dec 07
2020
|
Charles Albright EVP/Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+30.81%
|
$320,000
$16.51 P/Share
|
|
Nov 09
2020
|
Charles Albright EVP/Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
228
-0.91%
|
$7,068
$31.21 P/Share
|
|
Nov 09
2020
|
Lisa Anne Michaels EVP/Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Oct 15
2020
|
Charles Albright EVP/Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,000
-10.66%
|
$93,000
$31.39 P/Share
|